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Abstract
Background: Atherosclerotic ischemic renal disease is a frequent cause of end-stage renal failure
leading to dialysis among the elderly; Its prevalence is inferred from autopsy or retrospective
arteriographic studies. This study has been conducted on 269 subjects over 50 with hypertension
and/or CRF, unrelated to other known causes of renal disease.
Methods: All 269 patients were studied either by color-flow duplex sonography (n = 238) or by
renal scintigraphy (n = 224), and 199 of the 269 patients were evaluated using both of these
techniques. 40 patients, found to have renal artery stenosis (RAS), were subjected to 3D-contrast
enhancement Magnetic Resonance Angiography (MRA) and/or Selective Angiography (SA). An
additional 23 cases, negative both to scintigraphy and to ultrasound study, underwent renal
angiography (MRA and/or SA).
Results: Color-duplex sonography, carried out in 238 patients, revealed 49 cases of RAS. MR or
SA was carried out in 35 of these 49 patients, and confirmed the diagnosis in 33. Color-duplex
sonography showed a PPV value of 94.3% and NPV of 87.0% while renal scintigraphy, carried out
in 224 patients, had a PPV of 72.2% and a NPV of 29.4%. Patients with RAS showed a higher degree
of renal insufficiency compared to non stenotic patients while there were no differences in
proteinuria. RAS, based on color-duplex sonography studies, was present in 11% of patients in the
age group 50–59, 18% in the 60–69 and 23% at age 70 and above.
Conclusions: A relatively large percentage of the elderly population with renal insufficiency and/
or hypertension is affected by RAS and is at risk of developing end-stage renal failure. Color-duplex
ultrasonography is a valid routine method of investigation of population at risk for renal artery
stenosis.
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Background
Ischemic renal disease is a renal insufficiency associated
with main renal artery stenosis or occlusion [1,2]. Chronic
ischemia causes progressive renal damage with atrophy
and permanent loss of structural integrity. The cause-and-
effect relationship between anatomic renal artery disease
and renal function is often difficult to establish [3]. Dete-
rioration of renal function derives not only from reduc-
tion in blood flow, but also from long term hypertension
and concomitant risk factors like diabetes, hyperlipi-
demia, atheroemboli and aging [4].
Ischemic nephropathy has been recognized in the last dec-
ade as a distinct cause of renal insufficiency, especially in
patients with advanced age [5]. A substantial percentage
of patients with endstage renal failure which requires en-
tering a dialysis program, is primarily affected by ischemic
renal disease [6,7]. Estimates of the prevalence of renovas-
cular disease derive mainly from autopsy and angiograph-
ic studies of patients with renovascular hypertension or
atherosclerotic disease involving other districts of the arte-
rial tree [8–11]. Large population studies based on non in-
vasive diagnostic methods are lacking.
The aim of this study is to evaluate the prevalence of renal
artery stenosis in a relatively large population aged 50 and
above, with arterial hypertension started over 50 years of
age, or with chronic renal failure of late onset not ex-
plained by other diagnoses. The study is also aimed at
comparing different diagnostic techniques for the detec-
tion of renal artery stenosis as well as clinical and bio-
chemical indicators of renovascular disease.
Methods
This study has been carried out on 269 patients, consecu-
tively referred to the nephrologic outpatient clinic for ar-
terial hypertension and/or chronic renal failure. Patients
were selected according to the following criteria: age
above 50 years, arterial hypertension starting after this age
and/or chronic renal failure of late onset, with or without
hypertension and unexplained by other known renal
pathologies such as chronic glomerulonephritis, chronic
tubulointerstitial disease, polycystic kidneys and obstruc-
tive renal disease. Diabetes mellitus was not an exclusion
criterion and cases of suspected diabetic nephropathy
were included when extrarenal atherosclerotic arterial oc-
clusive disease coexisted. None of the patients was on di-
alysis treatment or had received a kidney transplantation.
269 patients, 150 males and 119 females, were character-
ized for clinical and standard biochemical parameters, as
reported in Table 1, and subjected to non invasive diag-
nostic manoeuvres, such as renal radionuclide scintigra-
phy and color-duplex ultrasonography of renal arteries. In
particular, all 269 patients were studied either by color-
flow duplex sonography (n= 238) or by renal scintigraphy
(n= 224), and 199 of the 269 patients were evaluated us-
ing both of these techniques. 40 of 58 patients who were
positive for renal artery stenosis with one or two tech-
niques, underwent renal angiography either with three-di-
mensional contrast-enhanced Magnetic Resonance
Angiography (3D-CE-MRA), and/or with Selective Angi-
ography (SA). 7 of the remaining 18 patients could not be
subjected to Magnetic Resonance Angiography because of
technical problems (metallic prosthesis or pacemaker); 7
refused the procedure due to claustrophobia. In the re-
maining 4 cases, renal artery stenosis was on a small kid-
ney. In particular, of 49 patients with a positive
ultrasonography, 35 accepted to be submitted to renal an-
giography, while of 24 patients with a positive scintigra-
phy, 18 accepted to undergo renal angiography. In
addition, 17 patients with negative results for renal artery
stenosis with the non invasive manoeuvres, accepted to be
submitted to Magnetic Resonance Angiography.
Doppler ultrasonography was carried out after fasting, fol-
lowing a three day of a low fibre diet and without smoking
for a minimum of six hours before the procedure. Patients
were studied with an Acuson 120 XP/4 (Acuson Corp.,
Mountain View, CA), equipped with a 3.5 MHz transduc-
er, with longitudinal anterior, lateral and oblique ap-
proach, with at least threefold sampling of parameters
along the artery. Subjects were asked to lie in the supine
position for the study of the abdominal aorta and the or-
igin of the renal arteries. Subsequently patients were
turned on either side for the study of the renal arteries at
the hilum and of parenchymal perfusion.
Standard criteria for the diagnosis of significant renal ar-
tery stenosis (≥ 60%) are [12]: 1. Systolic peak velocity
above 180 cm/sec (sensitivity   94%, or 98% when peak
velocity >200 cm/sec). 2. Renal aortic ratio, defined as the
ratio between systolic peak velocity in the renal artery and
systolic peak velocity in the abdominal aorta in the supra-
renal tract, with a normal value of <3.5.
Renal radionuclide scintigraphy was performed with a
gamma camera (Starcam 4000, General Electric, USA)
with 99mTc-DTPA (diethylenetriaminepentaacetic acid) in
125 patients and with 99mTc-MAG3 (mercaptoacetyltrig-
lycine) in 99 patients, with a total of 224 patients. MAG3
was chosen in patients with creatinine clearance <25 ml/
min. Diuretics and/or ACE inhibitors were discontinued
at least three days before, if treatment was underway. Cri-
teria of positivity for renal artery stenosis were: Parenchy-
mal transit time >4 minutes; a difference in split renal
function >30%; Tmax >5 min, with a difference between
kidneys >1 min. A captopril test was carried out in 161 pa-
tients, by administering captopril 50 mg p.o. one hour be-
fore the administration of the tracer. Following captopril
≅BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/2
Page 3 of 7
(page number not for citation purposes)
administration, criteria of suspected stenosis were: with
99mTc-DTPA, a fall in glomerular filtration rate of the af-
fected side >5%; with 99mTc-MAG3, an increase of at least
0.15 of the 20 minutes/peak count ratio (ratio between
the activity after 20 minutes and peak radioactivity); or a
lengthening of >2 min of Tmax value, or a delay of tracer
elimination in the pelvis of >2 minutes [13,14].
Magnetic Resonance Angiography was performed with a
1.5 T magnet (Vision Plus; Siemens, Erlangen, Germany)
with 25 mT/m gradient strengtth and 600 microseconds
gradient rise time. In all cases a Flash 3D T1-weighted se-
quence (TR = 4.6; TE = 1.8, FA = 30°, NEX = 1, Slab thick-
ness = 120, FOV = 500, matrix = 200 × 512, n° partitions
= 34) was used. The acquisition time of the sequence was
23 s. A phased array body coil was used. Before the acqui-
sition a test bolus was performed (TR = 5.8, TE = 2.4, FA =
10, Thickness = 10, matrix-128 × 256, FOV = 400, NEX =
40), injecting 2 ml of Gd-DTPA at 2 ml/s; in order to es-
tablish the correct delay time. The examination was per-
formed administering 0.2 mmol/kg of Gd-DTPA with a
power injector (Spectris, Medrad) at a flow rate of 2 ml/s.
Images were reconstructed using a standard maximum in-
tensity projection (MIP) algorithm and were reviewed by
two radiologists obtaining a final report by consensus.
This is a more advanced technique than TOF-MRA (Time
of Fly) and PC-MRA (Phase-Contrast), and is especially
useful for detection of renal artery stenosis. It is consid-
ered to have specificity and sensitivity values approaching
selective angiography [15,16].
MR angiography was carried out in a total of 39 patients,
22 with positivity of at least one of the non invasive
manoeuvers, and 17 cases with negative results. Selective
angiography was carried out in 32 patients among those
with at least one positivity for renal artery stenosis, diag-
nosed with non invasive techniques. Stenosis was consid-
ered significant both with MRA and SA when at inspection
the reduction in arterial lumen diameter was ≥ 60%. In 14
patients, both MRA and SA were performed. The presence
of renal artery stenosis, identified by MRA, was confirmed
in all cases by SA. The total number of angiographic stud-
ies was 57.




Age, years 65,8 ± 11,9
Weight, Kg 70,8 ± 11,9
Creatinine, mg/dl 1,7 ± 1 (0,6–1,2)
Cr. Clearance, ml/min 54,8 ± 30,2 (90–120)
Urea, mg/dl 61,2 ± 33,2 (10–45)
Uric acid, mg/dl 6,5 ± 1,8 (3–7)
Sodium, mEq/L 142 ± 4,3 (136–145)
Potassium, mEq/L 4,6 ± 0,5 (3,6–5)
Cholesterol, mg/dl 243 ± 53 (150–220)
HDL cholesterol, mg/dl 49 ± 13,6 (>45)
Triglycerides, mg/dl 162 ± 83 (50–200)
Urinary protein, mg/24 h 654 ± 1103 (<150)
Systolic BP, mmHg 170 ± 25 (<140)
Diastolic BP, mmHg 96 ± 14 (<90)
Duration of hypertension, years 7,5 ± 6
n° %
Arterial hypertension 238 88,5
Familiar hypertension 113 42,0
Smoking 89 33,0
Diabetes mellitus 42 15,6
Hypertensive retinopathy (stage III and IV) 
(163/269)
42 , 5
Interventricular septum (154/269) 121 78,5
Stenosis of epiaortic arteries (111/269) 60 54,0
Stenosis of iliofemoral arteries (52/269) 33 63,5
Renal dimensions asymmetry (>11 mm) 135 50,2BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/2
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Statistical analysis
Following a preliminary descriptive analysis, since the
available data did not allow to evaluate sensitivity and
specificity, contingency tables were created only for evalu-
ation of positive and negative predictive values for the di-
agnostic techniques,. For each index the confidence
interval at 95% level was calculated. Mann-Withney non
parametric and Pearson χ2 tests were used. Significance
threshold level was considered to be p < 0.05.
Results
The number of patients, sex distribution, average age,
blood pressure values and several biochemical parameters
for the entire population together with other clinical pa-
rameters of the population are reported in Table 1.
The population was found to have, on average, a moder-
ate renal insufficiency, as shown by the mean creatinine
clearance of 54.8 ± 30.2 ml/min. 88.5% of the patients
had arterial hypertension. Hypertensive organ damage
was evidenced by a thickening of interventricular septum
in 78.5% of cases, revealed by echocardiography. In addi-
tion, on average the patients had increased cholesterol lev-
els. Carotid and lower extremities artery stenosis were
found in 54% and 63% respectively, of the patients stud-
ied. Diabetes mellitus was present in 15.6 %.
A synopsis of the results of the non-invasive techniques is
reported in Table 2. Renal color-duplex sonography, per-
formed in 238 patients, showed that 49 (20.6%) were af-
fected by renal artery stenosis. MRA and/or SA were
performed in 35 of these 49 patients. The diagnosis was
confirmed in 33 cases, while 2 cases were false positive. 23
of 189 patients with a negative result of color-duplex
sonography, accepted to undergo a renal angiography. In
20 cases the angiography confirmed the negativity, while
3 cases were found to be false negative. On the basis of
these data the positive predictive value of color-duplex
sonography was 94.3% (80.8–99.3% Confidence Inter-
val) and the negative predictive value was 87.0% (66.4–
97.2% C.I.).
Renal scintigraphy was carried out in 224 patients. 24 pa-
tients had a positive test for renal artery stenosis. 18 of 24
patients underwent an angiography. Positivity for renal
artery stenosis was confirmed in 13, while 5 cases were
false positive. Of 200 cases with negative results, 17 were
further examined with angiography; 12 of these cases were
false negative. The positive predictive value was 72.2%
(46.5–90.3% C.I.), while the negative predictive value was
29.4% (10.3–56.0% C.I.).
The comparison between patients with and without renal
artery stenosis (Table 3), based on the results of color-du-
plex sonography, has shown significant difference in the
extent of renal failure. The levels of proteinuria did not
reach statistical difference probably due to the groups siz-
es. Significant difference was also found in the prevalence
of renal asymmetry and in percent of patients with diabe-
tes mellitus (Table 3). 59% of the patients had a unilateral
stenosis while it was bilateral in 41%. The comparison of
renal damage between patients with unilateral and bilat-
eral renal artery stenosis in reported in Table 4.
Renal artery stenosis was found in 11.1% of patients in
the 50–59 age group, in 18% in the decade 60–69 and
23% of patients above 70 years of age.
Discussion
The primary aim of this study is to evaluate the diagnostic
role of the non invasive approach to renal artery stenosis
and ischemic nephropathy in the elderly, to compare the
clinical and biochemical data of patients with and with-
out ischemic nephropathy and to establish the prevalence
of this disease among the selected population in the dif-
ferent decades of life.
Based on a comparison between non invasive techniques
such as renal scintigraphy and color-duplex sonography,
and the diagnostic gold-standard of arteriography, that is
both Magnetic Resonance and/or Selective Angiography,
we attempted to assign predictive values to these non in-
vasive techniques. There is sufficient agreement between
Table 2: Synopsis of results of non-invasive techniques
DDS
RS Pos Neg Not Tested All
Pos 22 0 2 24
Neg 27 150 23 200
No tested 0 39 6 45
All 49 189 31 269BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/2
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MRA and SA to combine the outcomes for use as a gold-
standard. The good agreement was probably due at least
in part to the particular sensitivity and specificity of the
MR technique utilized in this study, which is considered
superimposable to selective angiography [15–17], at least
for the stenosis at the origin or at main renal artery. All our
cases tested with both arteriographic techniques had
comparable results as far as the presence of renal artery
stenosis is concerned. The identity of results has been re-
ported by De Cobelli et al. [18] and by Ghantous et al
[15].
There are some limitations in the use of Magnetic Reso-
nance, such as claustrophobia and the presence of pace-
makers or metallic prosthesis. Since Magnetic Resonance
is generally not employed on a routine basis for screening
purposes in large populations due to cost and availability,
the less expensive non-invasive imaging techniques
should come first in the preselection of affected patients.
In the comparison between color-doppler sonography
and radionuclide scintigraphy, unfortunately based on a
limited number of patients, the former was apparently
clearly superior in terms of positive and negative predic-
tive values, in agreement with data of the literature [19].
However this technique requires an experienced operator
in order to reach high levels of reliability. On the other
hand, in screening for ischemic nephropathy, among pa-
tients with renal insufficiency, radionuclide scintigraphy
was clearly less reliable, either using DTPA or MAG3. This
technique may give better results in terms of sensitivity
and specificity in a population screened for renovascular
hypertension, in general with normal renal function. Sco-
ble et al [19] have underlined that radionuclide scintigra-
phy may give better results in the screening of renal artery
fibrous dysplasia, where hyperreninism is more frequent,
while it is of lower diagnostic value in the diagnosis of re-
nal ischemia.
Comparing patients with and without renal artery stenosis
in an elderly population, a higher grade of renal insuffi-
ciency in patients with renal artery stenosis emerged clear-
ly, whether the stenosis was unilateral (59%) or bilateral
(41%). Renal insufficiency was found in both groups (Ta-
ble 4). Therefore renal artery stenosis in the elderly is as-
sociated to atherosclerotic vascular involvement of both
kidneys, with bilateral damage to renal function. It is mis-
leadingly simplistic to consider the overall renal damage
as deriving from reduced blood perfusion of the kidney,
due to renal artery stenosis. The poor correlation existing
between the extent of renal artery stenosis and degree of
renal insufficiency has been reported previously [3,20]. As
for arterial hypertension, no difference was found be-
tween stenotic and non stenotic patients (Table 3).
The observation concerning proteinuria is also of interest.
The extent of proteinuria did not seem to differ between
patients with and without renal artery stenosis, probably
Table 3: Humoral parameters (M ± SD) and percentage of clinical findings in patients with and without renal arterial stenosis
with without P
Patient, n° 49 189
Age, years 68,1 ± 8 66,3 ± 8,9 0,18
Creatinine, mg/dl 2,5 ± 1,5 1,6 ± 0,06 <,00001
Cr. Clearance, ml/min 34, 7 ± 19,2 58,2 ± 30,8 <,00001
Urea, mg/dl 84 ± 38 57 ± 29 <,00001
Uric acid, mg/dl 6,9 ± 1,8 6,4 ± 1,8 0,07
Sodium, mEq/L 142 ± 4,9 142,2 ± 4 0,6
Potassium, mEq/L 4,6 ± 0,5 4,5 ± 0,4 0,52
Cholesterol, mg/dl 236 ± 58 229 ± 54 0,15
HDL cholesterol, mg/dl 45,6 ± 12 49,6 ± 12 0,06
Triglycerides, mg/dl 176 ± 74 156 ± 76 0,08
Urinary protein, mg/24 h 659 ± 672 595 ± 980 0,14
Systolic BP, mmHg 175 ± 29 166 ± 21 0,07
Diastolic BP, mmHg 93 ± 15 94 ± 13 0,44
%%
Smoking 28,4 31,8 ns
Diabetes mellitus 29,8 13,6 <,01
Hypertensive retinopathy (stage III and IV) 6,1 6,1 ns
Interventricular septum 88,0 74,5 ns
Stenosis of epiaortic arteries 30,0 15,2 ns
Stenosis of iliofemoral arteries 57,1 50,0 ns
Renal dimensions asymmetry (>11 mm) 75,6 43,9 <,001BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/2
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due to the given groups sizes. Therefore the exclusion of
patients with proteinuria higher than 500 mg/day from
further diagnostic procedures for renal artery stenosis, ap-
pears to be unjustified [21,22]. More recently the occur-
rence of marked proteinuria in patients with ischemic
nephropathy has been reported [23,24]. Therefore our
data support the hypothesis that atherosclerotic renal in-
volvement may be accompanied by pathologic proteinu-
ria. On the other hand heavy proteinuria is of frequent
occurrence in nephroangiosclerosis, focal glomeruloscle-
rosis and cholesterol emboli, conditions found in ischem-
ic nephropathy [25–27] among the elderly.
The data of the medical literature on the prevalence of
ischemic renal disease in the elderly are scarce, derived
mainly from autoptic findings or from arteriography stud-
ies performed for coronary artery disease [7–10]. Our re-
sults based on color-duplex ultrasonography findings
indicate an elevated occurrence of this disease in this co-
hort, with an increasing prevalence from the sixth decade,
and reaching above 20% after age 70. Therefore the pres-
ence of ischemic nephropathy should be considered in
elderly patients affected by unexplained renal insufficien-
cy and/or hypertension of late onset. The possible evolu-
tion towards further deterioration of renal function in
patients with renal artery stenosis and the results of rela-
tively non-invasive renal stenting procedures for preven-
tion and treatment, are indication for an extensive
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